Cargando…
Cortex-wide topography of 1/f-exponent in Parkinson’s disease
Parkinson’s disease (PD) is a progressive and debilitating brain disorder. Besides the characteristic movement-related symptoms, the disease also causes decline in sensory and cognitive processing. The extent of symptoms and brain-wide projections of neuromodulators such as dopamine suggest that man...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338503/ https://www.ncbi.nlm.nih.gov/pubmed/37438362 http://dx.doi.org/10.1038/s41531-023-00553-6 |
_version_ | 1785071642311917568 |
---|---|
author | Helson, Pascal Lundqvist, Daniel Svenningsson, Per Vinding, Mikkel C. Kumar, Arvind |
author_facet | Helson, Pascal Lundqvist, Daniel Svenningsson, Per Vinding, Mikkel C. Kumar, Arvind |
author_sort | Helson, Pascal |
collection | PubMed |
description | Parkinson’s disease (PD) is a progressive and debilitating brain disorder. Besides the characteristic movement-related symptoms, the disease also causes decline in sensory and cognitive processing. The extent of symptoms and brain-wide projections of neuromodulators such as dopamine suggest that many brain regions are simultaneously affected in PD. To characterise brain-wide disease-related changes in neuronal function, we analysed resting state magnetoencephalogram (MEG) from two groups: PD patients and healthy controls. Besides standard spectral analysis, we quantified the aperiodic components (κ, λ) of the neural activity by fitting a power law κ/f(λ) – f is the frequency, κ and λ are the fitting parameters—to the MEG power spectrum and studied its relationship with age and Unified Parkinson’s Disease Rating Scale (UPDRS). Consistent with previous results, the most significant spectral changes were observed in the high theta/low-alpha band (7–10 Hz) in all brain regions. Furthermore, analysis of the aperiodic part of the spectrum showed that in all but frontal regions λ was significantly larger in PD patients than in control subjects. Our results indicate that PD is associated with significant changes in aperiodic activity across the whole neocortex. Surprisingly, even early sensory areas showed a significantly larger λ in patients than in healthy controls. Moreover, λ was not affected by the Levodopa medication. Finally, λ was positively correlated with patient age but not with UPDRS-III. Because λ is closely associated with excitation-inhibition balance, our results propose new hypotheses about neural correlates of PD in cortical networks. |
format | Online Article Text |
id | pubmed-10338503 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-103385032023-07-14 Cortex-wide topography of 1/f-exponent in Parkinson’s disease Helson, Pascal Lundqvist, Daniel Svenningsson, Per Vinding, Mikkel C. Kumar, Arvind NPJ Parkinsons Dis Article Parkinson’s disease (PD) is a progressive and debilitating brain disorder. Besides the characteristic movement-related symptoms, the disease also causes decline in sensory and cognitive processing. The extent of symptoms and brain-wide projections of neuromodulators such as dopamine suggest that many brain regions are simultaneously affected in PD. To characterise brain-wide disease-related changes in neuronal function, we analysed resting state magnetoencephalogram (MEG) from two groups: PD patients and healthy controls. Besides standard spectral analysis, we quantified the aperiodic components (κ, λ) of the neural activity by fitting a power law κ/f(λ) – f is the frequency, κ and λ are the fitting parameters—to the MEG power spectrum and studied its relationship with age and Unified Parkinson’s Disease Rating Scale (UPDRS). Consistent with previous results, the most significant spectral changes were observed in the high theta/low-alpha band (7–10 Hz) in all brain regions. Furthermore, analysis of the aperiodic part of the spectrum showed that in all but frontal regions λ was significantly larger in PD patients than in control subjects. Our results indicate that PD is associated with significant changes in aperiodic activity across the whole neocortex. Surprisingly, even early sensory areas showed a significantly larger λ in patients than in healthy controls. Moreover, λ was not affected by the Levodopa medication. Finally, λ was positively correlated with patient age but not with UPDRS-III. Because λ is closely associated with excitation-inhibition balance, our results propose new hypotheses about neural correlates of PD in cortical networks. Nature Publishing Group UK 2023-07-13 /pmc/articles/PMC10338503/ /pubmed/37438362 http://dx.doi.org/10.1038/s41531-023-00553-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Helson, Pascal Lundqvist, Daniel Svenningsson, Per Vinding, Mikkel C. Kumar, Arvind Cortex-wide topography of 1/f-exponent in Parkinson’s disease |
title | Cortex-wide topography of 1/f-exponent in Parkinson’s disease |
title_full | Cortex-wide topography of 1/f-exponent in Parkinson’s disease |
title_fullStr | Cortex-wide topography of 1/f-exponent in Parkinson’s disease |
title_full_unstemmed | Cortex-wide topography of 1/f-exponent in Parkinson’s disease |
title_short | Cortex-wide topography of 1/f-exponent in Parkinson’s disease |
title_sort | cortex-wide topography of 1/f-exponent in parkinson’s disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338503/ https://www.ncbi.nlm.nih.gov/pubmed/37438362 http://dx.doi.org/10.1038/s41531-023-00553-6 |
work_keys_str_mv | AT helsonpascal cortexwidetopographyof1fexponentinparkinsonsdisease AT lundqvistdaniel cortexwidetopographyof1fexponentinparkinsonsdisease AT svenningssonper cortexwidetopographyof1fexponentinparkinsonsdisease AT vindingmikkelc cortexwidetopographyof1fexponentinparkinsonsdisease AT kumararvind cortexwidetopographyof1fexponentinparkinsonsdisease |